Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 24Breast Neoplasms 14Colonic Neoplasms 11Pancreatic Neoplasms 10Rectal Neoplasms 9Lung Neoplasms 8Uterine Cervical Neoplasms 5Neoplasms 5Urinary Bladder Neoplasms 4Stomach Neoplasms 4Prostatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Ovarian Neoplasms 3Lymphoma 3Anxiety Disorders 3Pancreatic Cyst 2Melanoma 2Leukemia 2Kidney Neoplasms 2Endometrial Neoplasms 2Disease 2Depression 2Carcinoma, Renal Cell 2Carcinoma, Ovarian Epithelial 2Weight Loss 1Vulvar Neoplasms 1Uterine Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Thyroid Neoplasms 1

Interventions

Methods 1Immunotherapy 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Cancer Liver Metastases × Methods × Gastrointestinal × Clear all
NCT07333287 2026-01-12

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

Shandong Provincial Hospital

Phase 2 Not yet recruiting
38 enrolled
Gastrointestinal

Pancreatic Cancer Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡